AstraZeneca Sees $4B in COVID Vaccine Sales as Revenue Soars

Health

AstraZeneca Sees $4B in COVID Vaccine Sales as Revenue Soars

February 10, 2022

FILE - A general view of AstraZeneca offices and the corporate logo in Cambridge, England, Saturday, July 18, 2020. (AP Photo/Alastair Grant, File)

LONDON — AstraZeneca recorded a big jump in revenue on Thursday as it begins to take a profit from its coronavirus vaccine for the first time.

The company recorded full-year revenues of $37.4 billion, an increase of 38% from the year before at constant exchange rates. Part of the boost came from $4 billion in sales of its COVID-19 vaccine, developed with the University of Oxford.

Despite rising revenue, AstraZeneca reported a pre-tax loss of $265 million due to costs from its purchase of U.S. drug company Alexion Pharmaceuticals and new drug research.

The Anglo-Swedish drugmaker said in November it would begin to take a “modest” profit from the COVID-19 shot, which it had been providing “at cost” — around $2 to $3 —following an agreement with Oxford. Other COVID-19 vaccine producers, such as Pfizer and Moderna, have been booking hefty profits on their shots all along.

In the three months to September, the company said revenue jumped by about 50%, to a record $9.9 billion. The increase was due to sales of more than $1 billion in COVID-19 vaccines and the inclusion for the first time of some $1.3 billion worth of revenue from its rare disease business unit following the recent acquisition of Alexion.

AstraZeneca forecast total group sales to rise by a “high teens percentage” in 2022, but said COVID-19 revenues would decline by a “a low-to-mid twenties percentage.”

Chief executive Pascal Soriot said AstraZeneca had “delivered on our promise of broad and equitable access to our COVID-19 vaccine with 2.5 billion doses released for supply around the world.”

“AstraZeneca continued on its strong growth trajectory in 2021, with industry-leading R&D (research and development) productivity, five of our medicines crossing new blockbuster thresholds, and the acquisition and integration of Alexion,” he said.

Soriot said the company would raise the dividend to shareholders by 10 cents to $2.90, the first increase in a decade.

AstraZeneca shares were trading about 3% higher at 8.62 pounds ($11.68) on the London Stock Exchange on Thursday morning.

New York Greek Independence Parade Honors 1821 and Grim Anniversary for Cyprus (Vid & Pics)

NEW YORK – The New York Greek Independence Parade on Fifth Avenue, commemorating the 203rd anniversary of the Greek Revolution of 1821, was held in an atmosphere of emotion and pride on April 14.

Trump’s Historic Hush-Money Trial Gets Underway; 1st Day Ends without Any Jurors Being Picked

NEW YORK — The historic hush money trial of Donald Trump got underway Monday with the arduous process of selecting a jury to hear the case charging the former president with falsifying business records in order to stifle stories about his sex life.

Mitsotakis Presented New Democracy’s European Election Ballot Paper

ATHENS - The New Democracy's ballot paper was presented at a special event at the Athens Auditorium on Monday.

Israel’s Military Chief Says That Israel Will Respond to Iran’s Weekend Missile Attack

JERUSALEM — Israel’s military chief said Monday that his country will respond to Iran’s weekend attack, but he did not elaborate on when and how as world leaders urged Israel not to retaliate, trying to avoid a spiral of violence in the Middle East.

Greek Adoptees to Meet in Louisville for Third Annual Reunion June 20-22

FRANKLIN, TN – After the amazing success of first two Annual Greek Adoptee Reunions in Nashville, TN, in August 2022 and in their homeland of Greece in October 2023, Greek-born adoptees are poised to converge on Louisville, KY, for the Third Annual Greek Adoptee Reunion, June 20-22.

Health